JP2023515202A5 - - Google Patents
Info
- Publication number
- JP2023515202A5 JP2023515202A5 JP2022551589A JP2022551589A JP2023515202A5 JP 2023515202 A5 JP2023515202 A5 JP 2023515202A5 JP 2022551589 A JP2022551589 A JP 2022551589A JP 2022551589 A JP2022551589 A JP 2022551589A JP 2023515202 A5 JP2023515202 A5 JP 2023515202A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- subject
- immunosuppressant
- diseases
- synthetic nanocarrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (19)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062981606P | 2020-02-26 | 2020-02-26 | |
| US202062981586P | 2020-02-26 | 2020-02-26 | |
| US202062981594P | 2020-02-26 | 2020-02-26 | |
| US202062981602P | 2020-02-26 | 2020-02-26 | |
| US202062981595P | 2020-02-26 | 2020-02-26 | |
| US202062981584P | 2020-02-26 | 2020-02-26 | |
| US202062981589P | 2020-02-26 | 2020-02-26 | |
| US202062981612P | 2020-02-26 | 2020-02-26 | |
| US62/981,589 | 2020-02-26 | ||
| US62/981,594 | 2020-02-26 | ||
| US62/981,595 | 2020-02-26 | ||
| US62/981,612 | 2020-02-26 | ||
| US62/981,606 | 2020-02-26 | ||
| US62/981,586 | 2020-02-26 | ||
| US62/981,584 | 2020-02-26 | ||
| US62/981,602 | 2020-02-26 | ||
| PCT/US2020/028132 WO2021211100A1 (en) | 2020-04-14 | 2020-04-14 | Methods and compositions for inducing autophagy |
| USPCT/US2020/028132 | 2020-04-14 | ||
| PCT/US2021/019927 WO2021174013A1 (en) | 2020-02-26 | 2021-02-26 | Methods and compositions using synthetic nanocarriers comprising immunosuppressant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023515202A JP2023515202A (ja) | 2023-04-12 |
| JP2023515202A5 true JP2023515202A5 (https=) | 2024-03-06 |
Family
ID=74947602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551589A Pending JP2023515202A (ja) | 2020-02-26 | 2021-02-26 | 免疫抑制薬を含む合成ナノキャリアを使用する方法および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210290601A1 (https=) |
| EP (1) | EP4110334A1 (https=) |
| JP (1) | JP2023515202A (https=) |
| KR (1) | KR20220146559A (https=) |
| CN (1) | CN115379839A (https=) |
| AU (1) | AU2021225955A1 (https=) |
| CA (1) | CA3173734A1 (https=) |
| IL (1) | IL295868A (https=) |
| MX (1) | MX2022010568A (https=) |
| WO (1) | WO2021174013A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX374963B (es) | 2011-04-29 | 2025-03-06 | Selecta Biosciences Inc | Nanoportadores sintéticos tolerogénicos para reducir las respuestas de anticuerpos. |
| BR122020023215B1 (pt) | 2013-05-03 | 2022-11-22 | Selecta Biosciences, Inc | Composição e kit de nanocarreadores sintéticos tolerogênicos para reduzir ou prevenir anafilaxia em resposta a um antígeno não alergênico |
| ES3036482T3 (en) | 2017-03-11 | 2025-09-19 | Cartesian Therapeutics Inc | Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant |
| AU2020287627A1 (en) | 2019-06-04 | 2021-11-18 | Selecta Biosciences, Inc. | Formulations and doses of PEGylated uricase |
| IL297274A (en) * | 2020-04-14 | 2022-12-01 | Selecta Biosciences Inc | Methods and compositions for inducing autophagy |
| ES2986744A1 (es) * | 2023-04-13 | 2024-11-12 | Servicio Andaluz De Salud | Rapamicina y estatinas como protectores frente daño hepático |
| CN117860782B (zh) * | 2024-03-11 | 2024-05-28 | 中国康复科学所(中国残联残疾预防与控制研究中心) | 双阴性t细胞在制备治疗脊髓损伤的药物中的用途 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946929A (en) | 1983-03-22 | 1990-08-07 | Massachusetts Institute Of Technology | Bioerodible articles useful as implants and prostheses having predictable degradation rates |
| US4638045A (en) | 1985-02-19 | 1987-01-20 | Massachusetts Institute Of Technology | Non-peptide polyamino acid bioerodible polymers |
| US4806621A (en) | 1986-01-21 | 1989-02-21 | Massachusetts Institute Of Technology | Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article |
| CA1340581C (en) | 1986-11-20 | 1999-06-08 | Joseph P. Vacanti | Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices |
| US5804178A (en) | 1986-11-20 | 1998-09-08 | Massachusetts Institute Of Technology | Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue |
| US5736372A (en) | 1986-11-20 | 1998-04-07 | Massachusetts Institute Of Technology | Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure |
| US5019379A (en) | 1987-07-31 | 1991-05-28 | Massachusetts Institute Of Technology | Unsaturated polyanhydrides |
| US5010167A (en) | 1989-03-31 | 1991-04-23 | Massachusetts Institute Of Technology | Poly(amide-and imide-co-anhydride) for biological application |
| US5399665A (en) | 1992-11-05 | 1995-03-21 | Massachusetts Institute Of Technology | Biodegradable polymers for cell transplantation |
| US5843452A (en) * | 1992-11-09 | 1998-12-01 | Pharmagenesis, Inc. | Immunotherapy composition and method |
| US5512600A (en) | 1993-01-15 | 1996-04-30 | Massachusetts Institute Of Technology | Preparation of bonded fiber structures for cell implantation |
| US5514378A (en) | 1993-02-01 | 1996-05-07 | Massachusetts Institute Of Technology | Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures |
| US5565215A (en) | 1993-07-23 | 1996-10-15 | Massachusettes Institute Of Technology | Biodegradable injectable particles for imaging |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| US6007845A (en) | 1994-07-22 | 1999-12-28 | Massachusetts Institute Of Technology | Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| US5716404A (en) | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
| US6123727A (en) | 1995-05-01 | 2000-09-26 | Massachusetts Institute Of Technology | Tissue engineered tendons and ligaments |
| US6095148A (en) | 1995-11-03 | 2000-08-01 | Children's Medical Center Corporation | Neuronal stimulation using electrically conducting polymers |
| US5902599A (en) | 1996-02-20 | 1999-05-11 | Massachusetts Institute Of Technology | Biodegradable polymer networks for use in orthopedic and dental applications |
| AU735648B2 (en) | 1996-07-12 | 2001-07-12 | Ariad Pharmaceuticals, Inc. | Materials and method for treating or preventing pathogenic fungal infection |
| US5837752A (en) | 1997-07-17 | 1998-11-17 | Massachusetts Institute Of Technology | Semi-interpenetrating polymer networks |
| US6632922B1 (en) | 1998-03-19 | 2003-10-14 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| US6686446B2 (en) | 1998-03-19 | 2004-02-03 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| US6506577B1 (en) | 1998-03-19 | 2003-01-14 | The Regents Of The University Of California | Synthesis and crosslinking of catechol containing copolypeptides |
| JP4751556B2 (ja) | 2000-02-28 | 2011-08-17 | ジーンシーグス， インコーポレイテッド | ナノカプセルカプセル化システムおよび方法 |
| GB0025414D0 (en) | 2000-10-16 | 2000-11-29 | Consejo Superior Investigacion | Nanoparticles |
| WO2003020797A1 (en) | 2001-08-30 | 2003-03-13 | The Regents Of The University Of California | Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers |
| MXPA06006738A (es) | 2003-12-19 | 2006-08-31 | Univ North Carolina | Metodos para fabricar micro- y nano-estructuras aisladas utilizando litografia suave o de impresion. |
| WO2006080951A2 (en) | 2004-07-01 | 2006-08-03 | Yale University | Targeted and high density drug loaded polymeric materials |
| WO2008127532A1 (en) | 2007-04-12 | 2008-10-23 | Emory University | Novel strategies for delivery of active agents using micelles and particles |
| JP2011500569A (ja) | 2007-10-12 | 2011-01-06 | マサチューセッツ インスティテュート オブ テクノロジー | ワクチンナノテクノロジー |
| CN101676291B (zh) | 2008-09-18 | 2012-05-09 | 上海海和药物研究开发有限公司 | 一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途 |
| MX374963B (es) * | 2011-04-29 | 2025-03-06 | Selecta Biosciences Inc | Nanoportadores sintéticos tolerogénicos para reducir las respuestas de anticuerpos. |
| BR122020023215B1 (pt) * | 2013-05-03 | 2022-11-22 | Selecta Biosciences, Inc | Composição e kit de nanocarreadores sintéticos tolerogênicos para reduzir ou prevenir anafilaxia em resposta a um antígeno não alergênico |
| US20150359865A1 (en) * | 2014-06-17 | 2015-12-17 | Selecta Biosciences, Inc. | Tolerogenic synthetic nanocarriers for t-cell-mediated autoimmune disease |
| KR102601922B1 (ko) | 2014-11-05 | 2023-11-15 | 셀렉타 바이오사이언시즈, 인크. | 안정한 과-포화 상태로 라파마이신을 포함하는 합성 나노담체와 관련된 방법 및 조성물 |
| WO2017139212A1 (en) * | 2016-02-08 | 2017-08-17 | Cyta Therapeutics, Inc. | Particle delivery of rapamycin to the liver |
| BR112020007157A2 (pt) * | 2017-10-13 | 2020-09-24 | Selecta Biosciences, Inc. | métodos e composições para a atenuação de respostas de igm antivetor de transferência viral |
| EP4048269A1 (en) * | 2019-10-21 | 2022-08-31 | Selecta Biosciences, Inc. | Methods and compositions for treating liver diseases and disorders |
| IL297274A (en) * | 2020-04-14 | 2022-12-01 | Selecta Biosciences Inc | Methods and compositions for inducing autophagy |
| WO2023133319A1 (en) * | 2022-01-10 | 2023-07-13 | Selecta Biosciences, Inc. | High affinity il-2 receptor agonists and synthetic nanocarrier dose sparing |
| US20230372535A1 (en) * | 2022-03-25 | 2023-11-23 | Selecta Biosciences, Inc. | Synthetic nanocarriers comprising an immunosuppressant in combination with high affinity il-2 receptor agonists and anti-igm agents |
| US20230381277A1 (en) * | 2022-04-08 | 2023-11-30 | Selecta Biosciences, Inc. | High affinity il-2 receptor agonists and immunosuppressants to enhance immune tolerance |
-
2021
- 2021-02-26 AU AU2021225955A patent/AU2021225955A1/en not_active Abandoned
- 2021-02-26 WO PCT/US2021/019927 patent/WO2021174013A1/en not_active Ceased
- 2021-02-26 CA CA3173734A patent/CA3173734A1/en active Pending
- 2021-02-26 KR KR1020227033127A patent/KR20220146559A/ko active Pending
- 2021-02-26 IL IL295868A patent/IL295868A/en unknown
- 2021-02-26 US US17/187,512 patent/US20210290601A1/en not_active Abandoned
- 2021-02-26 MX MX2022010568A patent/MX2022010568A/es unknown
- 2021-02-26 CN CN202180024338.9A patent/CN115379839A/zh active Pending
- 2021-02-26 JP JP2022551589A patent/JP2023515202A/ja active Pending
- 2021-02-26 EP EP21712927.9A patent/EP4110334A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023515202A5 (https=) | ||
| JP2019167350A5 (https=) | ||
| JP2020002140A5 (https=) | ||
| Yu et al. | Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response | |
| JP2017193568A5 (https=) | ||
| JP2018111687A5 (https=) | ||
| JP2014514331A5 (https=) | ||
| JP2017122111A5 (https=) | ||
| JP2014514334A5 (https=) | ||
| JP2014517828A5 (https=) | ||
| JP2014513092A5 (https=) | ||
| Bruestle et al. | Autoimmunity in acute myocarditis: how immunopathogenesis steers new directions for diagnosis and treatment | |
| JP2014514335A5 (https=) | ||
| Lewis et al. | Nanotherapeutics for inhibition of atherogenesis and modulation of inflammation in atherosclerotic plaques | |
| Horwitz et al. | Strategies to use nanoparticles to generate CD4 and CD8 regulatory T cells for the treatment of SLE and other autoimmune diseases | |
| JP2017122110A5 (https=) | ||
| Liu et al. | Generation of tolerogenic antigen-presenting cells in vivo via the delivery of mRNA encoding PDL1 within lipid nanoparticles | |
| Petersen et al. | Amphiphilic nanoparticles repress macrophage atherogenesis: novel core/shell designs for scavenger receptor targeting and down-regulation | |
| Shah et al. | Optimizing PLG nanoparticle-peptide delivery platforms for transplantation tolerance using an allogeneic skin transplant model | |
| Maccari et al. | Present and future of immunotherapy in patients with glioblastoma: limitations and opportunities | |
| Ochando et al. | Nanoparticle-based modulation and monitoring of antigen-presenting cells in organ transplantation | |
| JP2020513420A (ja) | 負の表面電荷を有するマイクロ粒子及びナノ粒子 | |
| Erdemli et al. | In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes | |
| Haycook et al. | PEGylated PLGA nanoparticle delivery of eggmanone for T cell modulation: applications in rheumatic autoimmunity | |
| Sousa et al. | Immunostimulatory nanoparticles delivering cytokines as a novel cancer nanoadjuvant to empower glioblastoma immunotherapy |